Chin Hur, MD, MPH

Associate Director, ITA Chin Hur
Associate Professor of Medicine, Harvard Medical School
Director of GI Health Outcomes Research, MGH Gastrointestinal Unit
Email: This email address is being protected from spambots. You need JavaScript enabled to view it.
Fax: 617-726-9414
Location: Institute for Technology Assessment
Massachusetts General Hospital
101 Merrimac St., STE 1010
Boston, MA 02114

Dr. Hur received his bachelor degree from Columbia University, his MD and MPH degrees from Johns Hopkins University and completed his Internal Medicine residency at the Johns Hopkins Hospital. He subsequently completed his fellowship in Gastroenterology at the Beth Israel Deaconess Medical Center and then joined the faculty of the MGH Gastrointestinal Unit in 2002.

Dr. Hur's areas of clinical areas of interests include: gastroesophageal reflux disease (GERD), Barrett's esophagus, esophageal adenocarcinoma as well as gastrointestinal cancer screening. His research interest lies in outcomes research, specifically technology assessment with a focus on decision analysis and disease modeling, and the application of these methodologies to the management of cancers and pre-malignant states (e.g. dysplasia) in the gastrointestinal tract. This management includes the identification of clinical predictors, diagnostic algorithms, and the optimization of treatment.

Some of the specific projects that he has been involved with include a disease model of Barrett's Esophagus and Esophageal Cancer, an analysis of the impact of the implementation of Virtual Colonoscopies for colorectal cancer (CRC) screening and the possible role for chemoprevention in cancer care.



  • Chu, J. N., Choi, J., Tramontano, A., Morse, C., Forcione, D., Nishioka, N. S., Abrams, J. A., Rubenstein, J. H., Kong, C. Y., Inadomi, J. M. & Hur, C. (2017). Surgical vs Endoscopic Management of T1 Esophageal Adenocarcinoma: a Modeling Decision Analysis. Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association, . [Online version]
  • Bethea, E., Chen, Q., Hur, C., Chung, R. T. & Chhatwal, J. (2017). Should we treat acute hepatitis C? A decision and cost-effectiveness analysis. Hepatology (Baltimore, Md.), . [Online version]
  • He, T., Lopez-Olivo, M. A., Hur, C. & Chhatwal, J. (2017). Systematic review: cost-effectiveness of direct-acting antivirals for treatment of hepatitis C genotypes 2-6. Alimentary pharmacology & therapeutics, . [Online version]
  • Tramontano, A., Sheehan, D., Yeh, J., Kong, C. Y., Dowling, E., Rubenstein, J. H., Abrams, J. A., Inadomi, J. M., Schrag, D. & Hur, C. (2017). The Impact of a Prior Diagnosis of Barrett's Esophagus on Esophageal Adenocarcinoma Survival. The American journal of gastroenterology, 112(8), 1256-1264. [Online version]
  • Kabrhel, C., Ali, A., Choi, J. & Hur, C. (2017). Systemic Thrombolysis, Catheter-Directed Thrombolysis and Anticoagulation for Intermediate-Risk Pulmonary Embolism: A Simulation Modeling Analysis. Academic emergency medicine : official journal of the Society for Academic Emergency Medicine, . [Online version]